CORRESP Filing
Silexion Therapeutics Corp
Date: Sept. 9, 2025 · CIK: 0002022416 · Accession: 0001178913-25-003278
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290074
Letter
Re:
Silexion Therapeutics Corp. 12 Abba Hillel Road Ramat Gan, Israel 5250606
September 9, 2025
Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549
Silexion Therapeutics Corp.
Registration Statement on Form S-1 Filed September 5, 2025 File No. 333-290074
VIA EDGAR
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Silexion Therapeutics Corp. (the “ Company ”) hereby respectfully requests that the effectiveness of the Registration Statement on Form S-1 (File No. 333-290074) of the Company (the “ Registration Statement ”) be accelerated so that the Company’s Registration Statement will become effective at 9:00 a.m., Eastern Time, on September 11, 2025 or as soon thereafter as may be practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, LLP, by calling Gary Emmanuel at (212) 801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.
Very truly yours,
SILEXION THERAPEUTICS CORP
Show Raw Text
CORRESP 1 filename1.htm Silexion Therapeutics Corp. 12 Abba Hillel Road Ramat Gan, Israel 5250606 September 9, 2025 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Silexion Therapeutics Corp. Registration Statement on Form S-1 Filed September 5, 2025 File No. 333-290074 VIA EDGAR Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Silexion Therapeutics Corp. (the “ Company ”) hereby respectfully requests that the effectiveness of the Registration Statement on Form S-1 (File No. 333-290074) of the Company (the “ Registration Statement ”) be accelerated so that the Company’s Registration Statement will become effective at 9:00 a.m., Eastern Time, on September 11, 2025 or as soon thereafter as may be practicable. The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, LLP, by calling Gary Emmanuel at (212) 801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration. Very truly yours, SILEXION THERAPEUTICS CORP By: /s/ Ilan Hadar Name: Ilan Hadar Title: Chief Executive Officer cc: Gary Emmanuel (Greenberg Traurig, LLP)